BACKGROUND: The physical activity levels of adult patients with cystic fibrosis hospitalised for an acute respiratory exacerbation is unknown. METHODS: A prospective observational study was undertaken. Physical activity levels were measured for a 24-h period using an activity monitor (SenseWear(®) Pro 3) during hospitalisation for an acute respiratory exacerbation and one month post-discharge. Measures of exercise tolerance and muscle strength were also recorded. RESULTS: Twenty-four patients completed the study. Most outcomes significantly increased from hospitalisation to one month post-discharge. Time spent doing physical activity (≥3 METs) increased from a mean ± SD of 95 ± 58 to 209 ± 111 min. CONCLUSIONS: Hospitalisation for an acute respiratory exacerbation was associated with less time spent performing physical activity compared to one month post-discharge. Physical activity levels were higher than anticipated, even during hospitalisation, suggesting an increased metabolic rate may have contributed to the physical activity levels documented. Activity level definitions for moderate intensity exercise that are based on higher MET levels seemed more appropriate in this patient setting. CLINICAL TRIAL REGISTRY: Australian New Zealand Clinical Trials Registry Number: ACTRN12610000595011. Crown
BACKGROUND: The physical activity levels of adult patients with cystic fibrosis hospitalised for an acute respiratory exacerbation is unknown. METHODS: A prospective observational study was undertaken. Physical activity levels were measured for a 24-h period using an activity monitor (SenseWear(®) Pro 3) during hospitalisation for an acute respiratory exacerbation and one month post-discharge. Measures of exercise tolerance and muscle strength were also recorded. RESULTS: Twenty-four patients completed the study. Most outcomes significantly increased from hospitalisation to one month post-discharge. Time spent doing physical activity (≥3 METs) increased from a mean ± SD of 95 ± 58 to 209 ± 111 min. CONCLUSIONS: Hospitalisation for an acute respiratory exacerbation was associated with less time spent performing physical activity compared to one month post-discharge. Physical activity levels were higher than anticipated, even during hospitalisation, suggesting an increased metabolic rate may have contributed to the physical activity levels documented. Activity level definitions for moderate intensity exercise that are based on higher MET levels seemed more appropriate in this patient setting. CLINICAL TRIAL REGISTRY: Australian New Zealand Clinical Trials Registry Number: ACTRN12610000595011. Crown
Authors: Daniela Savi; Nicholas Simmonds; Marcello Di Paolo; Serena Quattrucci; Paolo Palange; Winston Banya; Nicholas S Hopkinson; Diana Bilton Journal: BMC Pulm Med Date: 2015-12-01 Impact factor: 3.317
Authors: Heena Khiroya; Rebecca Pound; Ushna Qureshi; Catherine Brown; Joanne Barrett; Rifat Rashid; Joanna L Whitehouse; Alice M Turner; Edward F Nash Journal: Open Respir Med J Date: 2015-02-25
Authors: Jamie Wood; Sue Jenkins; David Putrino; Siobhain Mulrennan; Sue Morey; Nola Cecins; Kylie Hill Journal: BMJ Open Date: 2018-04-21 Impact factor: 2.692
Authors: Ren-Jay Shei; Kelly A Mackintosh; Jacelyn E Peabody Lever; Melitta A McNarry; Stefanie Krick Journal: Front Physiol Date: 2019-11-05 Impact factor: 4.566
Authors: Daniela Savi; Luigi Graziano; Barbara Giordani; Stefano Schiavetto; Corrado De Vito; Giuseppe Migliara; Nicholas J Simmonds; Paolo Palange; J Stuart Elborn Journal: BMC Pulm Med Date: 2020-10-30 Impact factor: 3.317